(Q45852208)

16 December 2017

title

Modelling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002. (English)

1 reference

16 December 2017

0 references

1 reference

coronary artery disease

1 reference

2

Annika Rosengren

1 reference

16 December 2017

author name string

Lena Björck

1

1 reference

16 December 2017

Kathleen Bennett

3

1 reference

16 December 2017

George Lappas

4

1 reference

16 December 2017

Simon Capewell

5

1 reference

16 December 2017

language of work or name

1 reference

13 January 2009

1 reference

16 December 2017

published in

European Heart Journal

1 reference

16 December 2017

volume

30

1 reference

16 December 2017

issue

9

1 reference

16 December 2017

page(s)

1046-1056

1 reference

16 December 2017

Dynamics of cardiovascular and all-cause mortality in Western and Eastern Europe between 1970 and 2000.

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN554

Trends in incidence and case fatality rates of acute myocardial infarction in Denmark and Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN554

Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN554

Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN554

No increase in the prevalence of known diabetes between 1986 and 1999 in subjects 25-64 years of age in northern Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN554

High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN554

Relative importance of improved hospital treatment and primary prevention. Results from 20 years of the Myocardial Infarction Register, Göteborg, Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN554

Trends in acute coronary heart disease mortality, morbidity, and medical care from 1985 through 1997: the Minnesota heart survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN554

Declining rates of coronary heart disease in New Zealand and Australia, 1983-1993.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN554

Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN554

Explaining the recent decrease in coronary heart disease mortality rates in Ireland, 1985-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN554

Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN554

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN554

Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN554

Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN554

Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN554

Optimal medical therapy with or without PCI for stable coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN554

Outpatient adherence to beta-blocker therapy after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN554

A critical evaluation of the methodology of the literature on medication compliance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN554

Detecting differences in quality of care: the sensitivity of measures of process and outcome in treating acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN554

A strategy to reduce cardiovascular disease by more than 80%

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN554

Two decades of progress in preventing vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN554

Systematic underestimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies: data from the BUPA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN554

Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN554

The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN554

Heart failure in different occupational classes in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN554

Psychosocial determinants of coronary heart disease in middle-aged women: a prospective study in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN554

Representation of the elderly, women, and minorities in heart failure clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN554

Sex differences in survival after myocardial infarction in Sweden; data from the Swedish National Acute Myocardial Infarction Register

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN554

Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN554

Decreasing one-year mortality and hospitalization rates for heart failure in Sweden; Data from the Swedish Hospital Discharge Registry 1988 to 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN554

Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN554

Explaining the Decline in Coronary Heart Disease Mortality in Finland between 1982 and 1997

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN554

21 January 2018

Identifiers

DOI

10.1093/EURHEARTJ/EHN554

1 reference

16 December 2017

1 reference

16 December 2017